234 related articles for article (PubMed ID: 16218478)
1. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y
Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
[TBL] [Abstract][Full Text] [Related]
2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
3. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
[TBL] [Abstract][Full Text] [Related]
4. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
Kobayashi K; Lopez LR; Matsuura E
Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
[TBL] [Abstract][Full Text] [Related]
5. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR
Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953
[TBL] [Abstract][Full Text] [Related]
6. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Matsuura E; Kobayashi K; Hurley BL; Lopez LR
Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
[TBL] [Abstract][Full Text] [Related]
7. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
[TBL] [Abstract][Full Text] [Related]
9. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
Matsuura E; Lopez LR
Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
Lopez LR; Kobayashi K; Matsunami Y; Matsuura E
Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
[TBL] [Abstract][Full Text] [Related]
11. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
Pengo V; Bison E; Ruffatti A; Iliceto S
Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune-mediated atherothrombosis.
Matsuura E; Lopez LR
Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
[TBL] [Abstract][Full Text] [Related]
14. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.
Romero FI; Amengual O; Atsumi T; Khamashta MA; Tinahones FJ; Hughes GR
Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680
[TBL] [Abstract][Full Text] [Related]
15. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis in autoimmune diseases.
Matsuura E; Kobayashi K; Lopez LR
Curr Rheumatol Rep; 2009 Feb; 11(1):61-9. PubMed ID: 19171113
[TBL] [Abstract][Full Text] [Related]
17. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.
Bassi N; Ghirardello A; Iaccarino L; Zampieri S; Rampudda ME; Atzeni F; Sarzi-Puttini P; Shoenfeld Y; Doria A
Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726
[TBL] [Abstract][Full Text] [Related]
18. Proatherogenic oxidized low-density lipoprotein/β2-glycoprotein I complexes in arterial and venous disease.
Berger JS; Rockman CB; Guyer KE; Lopez LR
J Immunol Res; 2014; 2014():234316. PubMed ID: 25405208
[TBL] [Abstract][Full Text] [Related]
19. Involvement of TLR4 in oxidized LDL/β2GPI/anti-β2GPI-induced transformation of macrophages to foam cells.
Zhang X; Xie Y; Zhou H; Xu Y; Liu J; Xie H; Yan J
J Atheroscler Thromb; 2014; 21(11):1140-51. PubMed ID: 24998486
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody-mediated atherosclerosis.
Matsuura E; Kobayashi K; Koike T; Shoenfeld Y
Autoimmun Rev; 2002 Dec; 1(6):348-53. PubMed ID: 12848990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
